Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The ones we don't have!

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Dec 09, 2020 8:33pm

235 Views

Post# 32073841

RE:RE:The ones we don't have!

Exceptional medical results.

Statistically significant Phase IIb clinical trial data shows that after median 5 years of follow-up, breast cancer patients treated with the GP2 immunotherapy had:

No cancer recurrences if fully immunized
No reported serious adverse events
A well tolerated safety profile

Greenwich LifeSciences plans to commence a Phase III clinical trial that is conservatively designed to reproduce the Phase IIb clinical trial results and to continue to save lives.

But the real fuel behind this stratospheric spike was this: